Skip to main content
TipRanks
Go Ultimate75% OFF

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Financial Statements

5 Followers

Jacobio Pharmaceuticals Group Co., Ltd. Financial Overview

Jacobio Pharmaceuticals Group Co., Ltd.'s market cap is currently ¥3.27B. The company's EPS TTM is ¥0.65; its P/E ratio is 5.43; Jacobio Pharmaceuticals Group Co., Ltd. is estimated to report earnings on March 24, 2027, and the estimated EPS forecast is ¥0.01. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 52.14M¥ 155.71M¥ 63.52M¥ 95.75M¥ 152.81M
Gross Profit¥ 29.35M¥ 155.71M¥ 3.20M¥ 12.63M¥ 12.83M
Operating Income¥ -165.68M¥ -188.17M¥ -397.88M¥ -394.20M¥ -319.38M
EBITDA¥ -142.87M¥ -176.73M¥ -325.73M¥ -355.80M¥ -289.83M
Net Income¥ -142.20M¥ -155.71M¥ -359.12M¥ -371.86M¥ -301.19M
Balance Sheet
Cash & Short-Term Investments¥ 1.10B¥ 1.17B¥ 1.15B¥ 1.28B¥ 1.54B
Total Assets¥ 1.30B¥ 1.36B¥ 1.46B¥ 1.57B¥ 1.72B
Total Debt¥ 165.24M¥ 152.08M¥ 209.91M¥ 147.79M¥ 6.81M
Net Debt¥ -778.41M¥ -1.02B¥ -933.21M¥ -1.14B¥ -1.52B
Total Liabilities¥ 533.92M¥ 435.99M¥ 387.11M¥ 292.12M¥ 84.75M
Stockholders' Equity¥ 770.96M¥ 923.18M¥ 1.07B¥ 1.28B¥ 1.64B
Cash Flow
Free Cash Flow¥ -187.27M¥ -86.21M¥ -402.86M¥ -308.92M¥ -158.63M
Operating Cash Flow¥ -186.20M¥ -74.12M¥ -364.20M¥ -292.42M¥ -147.49M
Investing Cash Flow¥ -138.63M¥ 256.22M¥ -48.00M¥ -686.32M¥ 161.67M
Financing Cash Flow¥ 45.20M¥ 21.28M¥ 246.28M¥ -9.85M¥ 109.06M

Currency in CNY

Jacobio Pharmaceuticals Group Co., Ltd. Earnings and Revenue History

-2B-1B01B-600 %-400 %-200 %0 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Jacobio Pharmaceuticals Group Co., Ltd. Liabilities to Assets

0800M1.6B2.4B0 %100 %200 %300 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Jacobio Pharmaceuticals Group Co., Ltd. Cash Flow

-1B-500M0500M1B1.5B20182019202020212022202320242025OperatingInvestingFinancing

Jacobio Pharmaceuticals Group Co., Ltd. Forecast EPS vs Actual EPS

-0.5-0.200.30.50.811.3Q2 24Q4 24Q2 25Q4 25Q2 26Q4 26EPS EstimateBeatMiss